Susmit Tripathi

Susmit Tripathi

Auto-generated profile, based on publicly available information

Susmit Tripathi

University of Maryland School of Medicine, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
SCSorayouth Chumnanvej
Sorayouth Chumnanvej
SCSiriluk Chumnanvej
Siriluk Chumnanvej
STSusmit Tripathi
Susmit Tripathi

21 January 2019 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
STSusmit Tripathi
Susmit Tripathi
JVJoe Verghese
Joe Verghese
HBHelena M. Blumen
Helena M. Blumen

1 December 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
KAKristin M. Allan
Kristin M. Allan
MLMatthew A. Loberg
Matthew A. Loberg
JCJuliet Chepngeno
Juliet Chepngeno
JHJennifer E. Hurtig
Jennifer E. Hurtig
STSusmit Tripathi
Susmit Tripathi
JWJames D. West
James D. West

20 January 2022 in The Neurologist
Verified
Journal Article
Closed access
STSusmit Tripathi
Susmit Tripathi
AMAshwin Malhotra
Ashwin Malhotra
MQMurtaza Qazi
Murtaza Qazi
JCJingyuan Bs Chou
Jingyuan Bs Chou
FWFei Wang
Fei Wang
HSHarini Sarva
Harini Sarva
Background: Parkinson’s disease (PD) is the second leading neurodegenerative disease worldwide. Important advances in monitoring and treatment have been made in recent years. This article reviews literature on utility of smartphone applications in monitoring PD symptoms that may ultimately facilitate improved patient care, and on movement modulation as a potential therapeutic. Review Summary: Novel mobile phone applications can provide one-time and/or continuous data to monitor PD motor symptoms in person or remotely, that may support precise therapeutic adjustments and management decisions. Apps have also been developed for medication management and treatment. Conclusions: Smartphone applications provide a wide array of platforms allowing for meaningful short-term and long-term data collection and are also being tested for intervention. However, the variability of the applications and the need to translate complicated sensor data may hinder immediate clinical applicability. Future studies should involve stake-holders early in the design process to promote usability and streamline the interface between patients, clinicians, and PD apps.

5 November 2013 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
MSMatthew K. Spencer
Matthew K. Spencer
NRNikolai P. Radzinski
Nikolai P. Radzinski
STSusmit Tripathi
Susmit Tripathi
SCSreyan Chowdhury
Sreyan Chowdhury
RHRachelle P. Herrin
Rachelle P. Herrin
JWJames D. West
James D. West

16 May 2025
Verified
Book Chapter
Closed access
STSusmit Tripathi
Susmit Tripathi
SCSorayouth Chumnanvej
Sorayouth Chumnanvej
Healthcare digital twin (HDT) technology originated in spaceflight planning before becoming a major driver of Industry 5.0 and precision medicine. Unlike traditional static models, HDT systems leverage cyber-physical integration via a bidirectional closed-loop between physical patients and their digital counterparts. AI systems process vast amounts of heterogeneous data from the “virtual” patient — electronic health records, genomics, radiomics, and wearable sensor outputs— to simulate and predict patient outcomes across multiple scales—from molecular interactions to population-wide health. Indeed, the current landscape of HDT applications spans key issues in patient-care and clinical trial optimization. Yet, technical, regulatory, and ethical challenges remain. This chapter explores the foundational concepts, technical frameworks, and current applications of digital twins, outlining both their transformative potential and the obstacles that must be navigated to fully realize their role in precision medicine.